Stockreport

Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights [Yahoo! Finance]

Structure Therapeutics Inc. - American Depositary Shares  (GPCR) 
PDF Oral small molecule amylin receptor agonist (ACCG-2671) Investigational New Drug (IND)-enabling activities underway; First-in-human Phase 1 initiation anticipated by ye [Read more]